{"transactions":[{"id":678898,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-08-21T20:30:11.000Z","date":"2026-08-19","kind":"sale","planned":true,"acquired":false,"shares":31487,"price":12.63,"value":397680.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares sold were acquired by the Reporting Person upon vesting of restricted stock units during the period from January 26, 2024 through January 26, 2026. The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $12.44 to $12.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":195444,"source":{"system":"sec-edgar","filing":"0001193125-26-361184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526361184/ownership.xml","form_type":"4"}},{"id":770111,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-05-20T20:05:18.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":2256,"price":9.3795,"value":21160.152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"2,256 shares were acquired on May 17, 2026 pursuant to the Issuer's Employee Stock Purchase Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.28 to $9.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":226931,"source":{"system":"sec-edgar","filing":"0001193125-26-232546","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526232546/ownership.xml","form_type":"4"}},{"id":930105,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:02.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":4777,"price":8.4607,"value":40416.7639,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24."}],"balance_after":226931,"source":{"system":"sec-edgar","filing":"0001193125-26-025301","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526025301/ownership.xml","form_type":"4"}},{"id":930104,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:02.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":2335,"price":8.4607,"value":19755.7345,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23."}],"balance_after":231708,"source":{"system":"sec-edgar","filing":"0001193125-26-025301","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526025301/ownership.xml","form_type":"4"}},{"id":930103,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:02.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":4096,"price":8.4607,"value":34655.0272,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25."}],"balance_after":234043,"source":{"system":"sec-edgar","filing":"0001193125-26-025301","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526025301/ownership.xml","form_type":"4"}},{"id":946960,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase common stock","published_at":"2026-01-06T21:30:04.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":100000,"derivative":{"exercise_price":10.335,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-26-004562","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526004562/ownership.xml","form_type":"4"}},{"id":946959,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:30:04.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30."}],"balance_after":238139,"source":{"system":"sec-edgar","filing":"0001193125-26-004562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526004562/ownership.xml","form_type":"4"}},{"id":998946,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:13.000Z","date":"2025-11-14","kind":"sale","planned":true,"acquired":false,"shares":8804,"price":11.1769,"value":98401.4276,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":188139,"source":{"system":"sec-edgar","filing":"0001193125-25-283568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312525283568/ownership.xml","form_type":"4"}},{"id":998945,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:13.000Z","date":"2025-11-13","kind":"grant","planned":true,"acquired":true,"shares":48900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":196943,"source":{"system":"sec-edgar","filing":"0001193125-25-283568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312525283568/ownership.xml","form_type":"4"}},{"id":1031268,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:08.000Z","date":"2025-09-29","kind":"sale","planned":true,"acquired":false,"shares":8805,"price":8.9422,"value":78736.071,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":148043,"source":{"system":"sec-edgar","filing":"0001193125-25-223666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312525223666/ownership.xml","form_type":"4"}},{"id":1031267,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:08.000Z","date":"2025-09-27","kind":"grant","planned":true,"acquired":true,"shares":48900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":156848,"source":{"system":"sec-edgar","filing":"0001193125-25-223666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312525223666/ownership.xml","form_type":"4"}},{"id":1142933,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-05-19T22:30:08.000Z","date":"2025-05-19","kind":"sale","planned":true,"acquired":false,"shares":1559,"price":5.96,"value":9291.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"1,559 shares were acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":107948,"source":{"system":"sec-edgar","filing":"0000950170-25-074660","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000095017025074660/ownership.xml","form_type":"4"}},{"id":1293131,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-01-29T01:38:49.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":4844,"price":7.8719,"value":38131.4836,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24."}],"balance_after":107948,"source":{"system":"sec-edgar","filing":"0000950170-25-010120","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000095017025010120/ownership.xml","form_type":"4"}},{"id":1293130,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-01-29T01:38:49.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":2437,"price":7.8719,"value":19183.8203,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23."}],"balance_after":112792,"source":{"system":"sec-edgar","filing":"0000950170-25-010120","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000095017025010120/ownership.xml","form_type":"4"}},{"id":1310899,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase common stock","published_at":"2025-01-06T21:08:09.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":92500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":92500,"derivative":{"exercise_price":8.68,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":92500},"source":{"system":"sec-edgar","filing":"0000950170-25-002062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000095017025002062/ownership.xml","form_type":"4"}},{"id":1310898,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-01-06T21:08:09.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":46250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/26, 1/26/27, 1/26/28 and 1/26/29."}],"balance_after":115229,"source":{"system":"sec-edgar","filing":"0000950170-25-002062","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000095017025002062/ownership.xml","form_type":"4"}},{"id":1509083,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-05-20T22:30:26.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":2615,"price":22.1477,"value":57916.2355,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"2615 shares were acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $22.06 to $22.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The reported sale of 2,615 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023."}],"balance_after":68979,"source":{"system":"sec-edgar","filing":"0000950170-24-062585","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000095017024062585/ownership.xml","form_type":"4"}},{"id":1665315,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-01-31T22:30:13.000Z","date":"2024-01-29","kind":"sale","planned":false,"acquired":false,"shares":2053,"price":17.8005,"value":36544.4265,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/23."}],"balance_after":68979,"source":{"system":"sec-edgar","filing":"0000950170-24-009495","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000095017024009495/ownership.xml","form_type":"4"}},{"id":1688077,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase common stock","published_at":"2024-01-04T21:07:17.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":92500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":92500,"derivative":{"exercise_price":15.36,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":92500},"source":{"system":"sec-edgar","filing":"0000950170-24-001847","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000095017024001847/ownership.xml","form_type":"4"}},{"id":1688076,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-01-04T21:07:17.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":46250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/25, 1/26/26, 1/26/27 and 1/26/28."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,657 shares acquired on May 17, 2023 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":71032,"source":{"system":"sec-edgar","filing":"0000950170-24-001847","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000095017024001847/ownership.xml","form_type":"4"}},{"id":2003780,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase common stock","published_at":"2023-02-21T22:13:04.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":138750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":138750,"derivative":{"exercise_price":11.99,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":138750},"source":{"system":"sec-edgar","filing":"0001209191-23-011287","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000120919123011287/doc4.xml","form_type":"4"}},{"id":2003779,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-02-21T22:13:04.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":23125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/24, 1/26/25, 1/26/26 and 1/26/27."}],"balance_after":23125,"source":{"system":"sec-edgar","filing":"0001209191-23-011287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000120919123011287/doc4.xml","form_type":"4"}},{"id":2110487,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-11-18T21:53:33.000Z","date":"2022-11-17","kind":"sale","acquired":false,"shares":2100,"price":15.2212,"value":31964.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"2,100 shares were acquired on November 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $15.08 to $15.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-057874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000120919122057874/doc4.xml","form_type":"4"}},{"id":2539450,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase common stock","published_at":"2021-10-19T21:13:05.000Z","date":"2021-10-18","kind":"grant","acquired":true,"shares":192000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest on the one year anniversary of the vesting commencement date, and 1/48th of the shares vest in 36 monthly installments thereafter."}],"balance_after":192000,"derivative":{"exercise_price":17.51,"expiration_date":"2031-10-17","underlying":"Common Stock","underlying_shares":192000},"source":{"system":"sec-edgar","filing":"0001209191-21-060952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000120919121060952/doc4.xml","form_type":"4"}},{"id":2613145,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, SVP Admin."}}],"security":"Restricted Stock Units","published_at":"2021-08-05T21:26:56.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on August 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on August 3, 2022."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-21-050011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000120919121050011/doc4.xml","form_type":"4"}},{"id":2613144,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, SVP Admin."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T21:26:56.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four equal annual installments beginning on August 3, 2022."}],"balance_after":37500,"derivative":{"exercise_price":3.8,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-21-050011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000120919121050011/doc4.xml","form_type":"4"}},{"id":3043864,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, SVP Admin."}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-31T20:09:21.000Z","date":"2020-08-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four equal annual installments beginning on August 27, 2021."}],"balance_after":15000,"derivative":{"exercise_price":10.26,"expiration_date":"2030-08-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-048745","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000120919120048745/doc4.xml","form_type":"4"}},{"id":3064935,"issuer":{"id":113753,"kind":"organization","name":"Athenex, Inc.","symbol":"ATNX"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, SVP Admin."}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-08T00:46:54.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in four equal annual installments beginning on August 5, 2021."}],"balance_after":60000,"derivative":{"exercise_price":11.4,"expiration_date":"2030-08-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-045792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000120919120045792/doc4.xml","form_type":"4"}}]}